Definitive Healthcare Corp.

NasdaqGS:DH Stock Report

Market Cap: US$636.7m

Definitive Healthcare Future Growth

Future criteria checks 0/6

Definitive Healthcare's revenue is forecast to decline at 1.4% per annum while its annual earnings are expected to grow at 96.6% per year. EPS is expected to grow by 96.1% per annum. Return on equity is forecast to be 6.6% in 3 years.

Key information

96.6%

Earnings growth rate

96.1%

EPS growth rate

Healthcare Services earnings growth32.9%
Revenue growth rate-1.4%
Future return on equity6.6%
Analyst coverage

Good

Last updated19 Dec 2024

Recent future growth updates

Recent updates

Definitive Healthcare: Poor Near-Term Outlook, But New CEO May Change Things

Aug 19

More Unpleasant Surprises Could Be In Store For Definitive Healthcare Corp.'s (NASDAQ:DH) Shares After Tumbling 28%

Aug 01
More Unpleasant Surprises Could Be In Store For Definitive Healthcare Corp.'s (NASDAQ:DH) Shares After Tumbling 28%

Definitive Healthcare: Weak Near-Term Growth To Put Valuation In Rangebound

Jun 25

Risks Still Elevated At These Prices As Definitive Healthcare Corp. (NASDAQ:DH) Shares Dive 26%

May 30
Risks Still Elevated At These Prices As Definitive Healthcare Corp. (NASDAQ:DH) Shares Dive 26%

Pinning Down Definitive Healthcare Corp.'s (NASDAQ:DH) P/S Is Difficult Right Now

Apr 14
Pinning Down Definitive Healthcare Corp.'s (NASDAQ:DH) P/S Is Difficult Right Now

Definitive Healthcare: Reiterate Buy Rating As I Expect Growth To Recover In FY25

Mar 19

Is Definitive Healthcare (NASDAQ:DH) Using Debt In A Risky Way?

Feb 16
Is Definitive Healthcare (NASDAQ:DH) Using Debt In A Risky Way?

An Intrinsic Calculation For Definitive Healthcare Corp. (NASDAQ:DH) Suggests It's 42% Undervalued

Dec 29
An Intrinsic Calculation For Definitive Healthcare Corp. (NASDAQ:DH) Suggests It's 42% Undervalued

Definitive Healthcare Corp. (NASDAQ:DH) Stock Rockets 31% As Investors Are Less Pessimistic Than Expected

Nov 24
Definitive Healthcare Corp. (NASDAQ:DH) Stock Rockets 31% As Investors Are Less Pessimistic Than Expected

Estimating The Fair Value Of Definitive Healthcare Corp. (NASDAQ:DH)

Jun 02
Estimating The Fair Value Of Definitive Healthcare Corp. (NASDAQ:DH)

Definitive Healthcare Corp. (NASDAQ:DH) First-Quarter Results Just Came Out: Here's What Analysts Are Forecasting For This Year

May 06
Definitive Healthcare Corp. (NASDAQ:DH) First-Quarter Results Just Came Out: Here's What Analysts Are Forecasting For This Year

A Look At The Fair Value Of Definitive Healthcare Corp. (NASDAQ:DH)

Dec 08
A Look At The Fair Value Of Definitive Healthcare Corp. (NASDAQ:DH)

Definitive Healthcare Grows Headcount Despite Gathering Recession Clouds

Aug 31

Definitive Healthcare Corp.'s (NASDAQ:DH) Intrinsic Value Is Potentially 27% Above Its Share Price

Jul 17
Definitive Healthcare Corp.'s (NASDAQ:DH) Intrinsic Value Is Potentially 27% Above Its Share Price

Definitive Healthcare: No Involvement Yet Here

Jun 05

Earnings and Revenue Growth Forecasts

NasdaqGS:DH - Analysts future estimates and past financials data (USD Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
12/31/2026250-17105889
12/31/2025241-20838513
12/31/2024250-437616813
9/30/2024256-3645355N/A
6/30/2024258-4054345N/A
3/31/2024256-2004143N/A
12/31/2023251-2023841N/A
9/30/2023246-1822532N/A
6/30/2023238-142533N/A
3/31/2023232-112837N/A
12/31/2022223-72736N/A
9/30/2022208-273944N/A
6/30/2022194-322932N/A
3/31/2022179-162225N/A
12/31/2021166-181825N/A
9/30/2021153-82430N/A
6/30/2021140N/A2631N/A
3/31/202112822530N/A
12/31/2020118N/A2223N/A
12/31/201986-362022N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: DH is forecast to remain unprofitable over the next 3 years.

Earnings vs Market: DH is forecast to remain unprofitable over the next 3 years.

High Growth Earnings: DH is forecast to remain unprofitable over the next 3 years.

Revenue vs Market: DH's revenue is expected to decline over the next 3 years (-1.4% per year).

High Growth Revenue: DH's revenue is forecast to decline over the next 3 years (-1.4% per year).

Earnings per Share Growth Forecasts

Future Return on Equity

Future ROE: DH's Return on Equity is forecast to be low in 3 years time (6.6%).

Discover growth companies

7D

1Y

7D

1Y

7D

1Y

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/01/02 22:52
End of Day Share Price 2025/01/02 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Definitive Healthcare Corp. is covered by 19 analysts. 13 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Joseph VruwinkBaird
Saket KaliaBarclays
Allen LutzBofA Global Research